140 related articles for article (PubMed ID: 11175837)
1. From angiogenesis to lymphangiogenesis.
Plate K
Nat Med; 2001 Feb; 7(2):151-2. PubMed ID: 11175837
[No Abstract] [Full Text] [Related]
2. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA; Paavonen K
Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
[TBL] [Abstract][Full Text] [Related]
4. Cartilage to bone--angiogenesis leads the way.
Harper J; Klagsbrun M
Nat Med; 1999 Jun; 5(6):617-8. PubMed ID: 10371495
[No Abstract] [Full Text] [Related]
5. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.
Mäkinen T; Jussila L; Veikkola T; Karpanen T; Kettunen MI; Pulkkanen KJ; Kauppinen R; Jackson DG; Kubo H; Nishikawa S; Ylä-Herttuala S; Alitalo K
Nat Med; 2001 Feb; 7(2):199-205. PubMed ID: 11175851
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
[TBL] [Abstract][Full Text] [Related]
8. Receptor tyrosine kinase signaling in vascular development.
Merenmies J; Parada LF; Henkemeyer M
Cell Growth Differ; 1997 Jan; 8(1):3-10. PubMed ID: 8993829
[No Abstract] [Full Text] [Related]
9. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD
Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies.
Aiello LP
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1647-52. PubMed ID: 9286253
[No Abstract] [Full Text] [Related]
11. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma.
Hoshino M; Nakamura Y; Hamid QA
J Allergy Clin Immunol; 2001 Jun; 107(6):1034-8. PubMed ID: 11398081
[TBL] [Abstract][Full Text] [Related]
13. Regulation of angiogenesis via vascular endothelial growth factor receptors.
Veikkola T; Karkkainen M; Claesson-Welsh L; Alitalo K
Cancer Res; 2000 Jan; 60(2):203-12. PubMed ID: 10667560
[No Abstract] [Full Text] [Related]
14. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.
Basu S; Nagy JA; Pal S; Vasile E; Eckelhoefer IA; Bliss VS; Manseau EJ; Dasgupta PS; Dvorak HF; Mukhopadhyay D
Nat Med; 2001 May; 7(5):569-74. PubMed ID: 11329058
[TBL] [Abstract][Full Text] [Related]
15. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
Oh H; Takagi H; Otani A; Koyama S; Kemmochi S; Uemura A; Honda Y
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):383-8. PubMed ID: 11756651
[TBL] [Abstract][Full Text] [Related]
16. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
[TBL] [Abstract][Full Text] [Related]
17. VEGF receptor signal transduction.
Matsumoto T; Claesson-Welsh L
Sci STKE; 2001 Dec; 2001(112):re21. PubMed ID: 11741095
[TBL] [Abstract][Full Text] [Related]
18. The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling.
Giorgetti-Peraldi S; Murdaca J; Mas JC; Van Obberghen E
Oncogene; 2001 Jul; 20(30):3959-68. PubMed ID: 11494124
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy.
Geng L; Donnelly E; McMahon G; Lin PC; Sierra-Rivera E; Oshinka H; Hallahan DE
Cancer Res; 2001 Mar; 61(6):2413-9. PubMed ID: 11289107
[TBL] [Abstract][Full Text] [Related]
20. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
Ng IO; Poon RT; Lee JM; Fan ST; Ng M; Tso WK
Am J Clin Pathol; 2001 Dec; 116(6):838-45. PubMed ID: 11764072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
